Phenotypic Effects of a Small Molecule CpxA Phosphatase Inhibitor on Uropathogenic Escherichia coli
ACS Infectious Diseases · 11.09.2026 · 12 (9) · 2995-3001
DOI: 10.1021/acsinfecdis.6c00457 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 21.08.2026. Verfasst von Alexis M Stoorza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota55414, United States. Hauptthemen laut MEDLINE: Uropathogenic Escherichia coli, Anti-Bacterial Agents, Enzyme Inhibitors, Bacterial Proteins. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Patients suffering from Urinary Tract Infections (UTIs) are faced with multidrug resistance and a lack of treatment options. An alternative strategy to traditional bactericidal drug design is to disarm pathogenic bacteria by targeting the regulation of virulence factors. Small-molecule CpxRA phosphatase inhibitor compound 26, hereafter referred to as Cpx26, has shown efficacy in a murine UTI model; however, the impact of pharmacological modulation of CpxRA on bacterial physiology is undefined. Herein, we report the activity of Cpx26 in phenotypic assays to provide insight into its mechanism of action and antivirulence properties. Cpx26 significantly inhibited swimming motility, biofilm formation, and adhesion to bladder epithelial cells at concentrations >60-fold below its MIC. Combination with first-line UTI antibiotics was explored, and synergy was observed with trimethoprim/sulfamethoxazole and fosfomycin, implying potential clinical benefit. This work highlights the potential of antivirulence therapies for prevalent infections such as UTIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota55414, United States.
- Department of Chemistry, University of Minnesota, Minneapolis, Minnesota55455, United States.
ORCID-Profile: Alexis M Stoorza, Erin E Carlson, Adam S Duerfeldt
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Stoorza, A. M., Carlson, E. E., & Duerfeldt, A. S. (2026). Phenotypic Effects of a Small Molecule CpxA Phosphatase Inhibitor on Uropathogenic Escherichia coli. ACS Infectious Diseases, 12(9), 2995-3001. https://doi.org/10.1021/acsinfecdis.6c00457
Vancouver
Stoorza AM, Carlson EE, Duerfeldt AS. Phenotypic Effects of a Small Molecule CpxA Phosphatase Inhibitor on Uropathogenic Escherichia coli. ACS Infectious Diseases. 2026;12(9):2995-3001. doi:10.1021/acsinfecdis.6c00457
BibTeX
@article{Stoorza2026,
author = {Stoorza, Alexis M and Carlson, Erin E and Duerfeldt, Adam S},
title = {Phenotypic Effects of a Small Molecule CpxA Phosphatase Inhibitor on Uropathogenic Escherichia coli},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {9},
pages = {2995--3001},
doi = {10.1021/acsinfecdis.6c00457}
}
EUVIMED